GlassScriptPhysician profile
Cindy Mesmer
NPI 1326478728
$4,093.72
in general payments reported to CMS, 2019-2025
32 companies · $1,438 in 2025
The $1,438 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $536 · 2022: $552 · 2023: $520 · 2024: $1,048 · 2025: $1,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,970 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,970.31 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $431.48 | 2022-2024 | Interstim |
| Sumitomo Pharma America, INC. | $413.17 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $379.49 | 2023-2025 | Eligard, Jatenzo |
| Endo USA, INC. | $256.08 | 2024-2025 | Xiaflex, Aveed |
| Abbvie INC. | $248.31 | 2021-2025 | |
| Janssen Biotech, INC. | $232.48 | 2021-2025 | Erleada, Akeega, Balversa |
| Accord Healthcare, INC. | $217.60 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $210.18 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $193.58 | 2021-2025 | |
| 180 Medical, INC. | $157.64 | 2021-2025 | Gentlecath, Cure Catheter |
| Mirati Therapeutics, INC. | $118.95 | 2023 | Krazati |
| Antares Pharma, INC. | $111.45 | 2021-2025 | Xyosted |
| Procept Biorobotics Corporation | $109.07 | 2021 | |
| Astellas Pharma US INC | $102.95 | 2021-2024 | Myrbetriq |
| Urovant Sciences INC | $90.13 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $88.70 | 2025 | |
| Dendreon Pharmaceuticals LLC | $87.55 | 2025 | Provenge |
| Convatec INC. | $71.25 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $66.60 | 2021-2025 | Prolaris, Myrisk |
| Myovant Sciences INC. | $63.20 | 2021-2022 | |
| Becton, Dickinson and Company | $58.17 | 2024-2025 | Bard Urinary Drainage Bag, Bard X-Force Balloon Dilation Catheter |
| Teleflex LLC | $54.71 | 2022-2023 | Urolift |
| Progenics Pharmaceuticals, INC. | $53.75 | 2022-2023 | Pylarify |
| Pfizer INC. | $52.96 | 2022-2025 | |
| Acerus Pharmaceuticals Corporation | $52.14 | 2021-2022 | |
| Telix Pharmaceuticals | $40.70 | 2024-2025 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $38.35 | 2025 | |
| Endo Pharmaceuticals INC. | $24.71 | 2024 | Xiaflex, Aveed |
| Boston Scientific Corporation | $21.46 | 2025 | Axonics |
| Olympus America INC. | $16.09 | 2022 | |
| Coloplast Corp | $15.93 | 2025 | |
| Axonics, INC. | $14.89 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Mesmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.